Department of Anesthesiology, Kyorin University School of Medicine, Tokyo, Japan.
J Anesth. 2009;23(4):534-42. doi: 10.1007/s00540-009-0797-5. Epub 2009 Nov 18.
The use of fluid therapy attempts to optimize blood circulation by manipulating the circulating blood volume (BV). BV may be a key intermediate parameter between fluid therapy and the blood circulation, and it has been assumed that BV can be controlled by fluid therapy. In order to construct a fluid therapy protocol, firstly, we have to confirm whether BV can actually be controlled by fluid therapy. Volume kinetics studies and dilution techniques for BV measurements have enabled the actual effects of fluid management on BV to be analyzed in the presence of various pathological conditions. Various studies have shown that the effect of fluid, especially crystalloid, on BV varies considerably among individuals, and even BV values measured at a single time point vary from 40 ml kg(-1) to 110 ml kg(-1). It has become apparent that such wide variations in interindividual BV preclude the establishment of universal optimal fluid management protocols. Thus, secondly, it should be clarified how BV is controlled, and whether or not we can control it. Perioperative BV reportedly changes in a manner that is independent of the in-out fluid balance, but is related to hormonal factors. Because inflammation and some hormones control vascular permeability and the renal adjustment of solutes and fluids, such factors may readjust the BV even after interventional fluid therapy. Perioperative BV may be predominantly controlled by an internal regulatory system, regardless of whether "restrictive" or "liberal" fluid management strategies are employed. Recognizing this physiological control of BV may help us to develop individualized fluid management strategies.
液体治疗的目的是通过操纵循环血容量 (BV) 来优化血液循环。BV 可能是液体治疗与血液循环之间的关键中间参数,并且已经假定 BV 可以通过液体治疗来控制。为了构建液体治疗方案,首先,我们必须确认 BV 是否可以实际通过液体治疗来控制。通过容积动力学研究和 BV 测量的稀释技术,可以在存在各种病理状况的情况下分析液体管理对 BV 的实际影响。各种研究表明,液体(尤其是晶体液)对 BV 的影响在个体之间差异很大,甚至在单个时间点测量的 BV 值也从 40ml/kg 到 110ml/kg 不等。很明显,BV 个体间如此大的差异排除了建立通用最佳液体管理方案的可能性。因此,其次,应该阐明 BV 是如何被控制的,以及我们是否可以控制它。据报道,围手术期 BV 的变化方式与进出液平衡无关,而是与激素因素有关。由于炎症和一些激素控制血管通透性和溶质及液体的肾脏调节,这些因素可能会在介入性液体治疗后重新调整 BV。围手术期 BV 可能主要由内部调节系统控制,无论采用“限制”还是“宽松”的液体管理策略。认识到 BV 的这种生理控制可能有助于我们开发个体化的液体管理策略。